RTTNews | Mar 8, 2021 09:21AM EST

09:20 Monday, March 8, 2021 (RTTNews.com) - Baxter International Inc. (BAX) and Moderna Inc. ( MRNA) said that they have reached an agreement by which Baxter BioPharma Solutions to provide fill/finish sterile manufacturing services and supply packaging for about 60-90 million doses of the Moderna COVID-19 Vaccine in 2021. Additional details of the agreement were not disclosed.

Baxter's BioPharma Solutions business is a premier contract manufacturing organization that specializes in parenteral (injectable) pharmaceuticals, including vaccines.

The manufacturing of the Moderna COVID-19 vaccine will take place at the BioPharma Solutions fill/finish sterile manufacturing facilities located in Bloomington, Indiana.

Read the original article on RTTNews ( https://www.rttnews.com/3175667/baxter-biopharma-reaches-deal-for-fill-finish-manufacturing-of-moderna-covid-19-vaccine-in-u-s.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved